Article
Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns.
Blood cancer journal - 19 Jun 2020
Schinke Carolina, Boyle Eileen M, Ashby Cody, Wang Yan, Lyzogubov Valeriy, Wardell Christopher, Qu Pingping, Hoering Antje, Deshpande Shayu, Ryan Katie, Thanendrarajan Sharmilan, Mohan Meera, Yarlagadda Naveen, Khan Maliha, Choudhury Samrat Roy, Zangari Maurizio, van Rhee Frits, Davies Faith, Barlogie Bart, Morgan Gareth, Walker Brian A
Abstract excerpt
Primary plasma cell leukemia (pPCL) is a rare and aggressive form of multiple myeloma (MM) that is characterized by the presence of ≥20% circulating plasma cells. Overall survival remains poor despite advances of anti-MM therapy. The disease biology as well as molecular mechanisms that distinguish pPCL from non-pPCL MM remain poorly understood and, given the rarity of the disease, are challenging to study. In an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
